Table 3.

Maternal Outcomes by Gestational Weight Gain after Diagnosis

	Gain Less than IOM Recommendations (n=175)	AOR (95% CI)	Within IOM Recommendations* (n=92)	Gain More than IOM Recommendations (n=368)	AOR (95% CI)	p
Preeclampsia	8 (4.6%)	0.40 (0.13–1.16)†	9 (9.8%)	64 (17.4%)	1.39 (0.62–3.13)†	<0.01
All Cesarean (Primary & Repeat)	64 (36.6%)	1.19 (0.65–2.19)§	29 (31.5%)	167 (45.4%)	1.78 (1.02–2.84)§	0.03
Primary Cesarean	29 (20.7%)	1.35 (0.63–2.93)‖	12 (16.0%)	84 (29.5%)	1.91 (0.94–3.88)‖	0.03
A2 GDM	56 (32.0%)	1.58 (0.82–3.01)‖	23 (25.0%)	170 (46.2%)	2.55 (1.42–4.56)‖	<0.01
Gestational Diabetes, Required Glyburide	55 (31.4%)	1.65 (0.86–3.19)‖	22 (23.9%)	162 (44.0%)	2.52 (1.39–4.56)‖	<0.01
Gestational Diabetes, Required Insulin	3 (1.7%)	-	2 (2.2%)	19 (5.2%)	-	0.04
Time to Blood Sugar Control (days)	14 (7–28)	-	7 (7–25)	14 (7–22)	-	0.89

Data presented as n (%) or median (interquartile range)

IOM = Institute of Medicine, A2 GDM = gestational diabetes requiring any pharmacologic agent

p-value is for χ² test for trend

^*Weight gain within IOM recommendations is reference

^†Adjusted for black race, prepregnancy BMI, and chronic hypertension

^§Adjusted for advanced maternal age, black race, and prior cesarean

^‖Adjusted for prepregnancy body mass index

^-Adjusted analysis not performed due to continuous variable or too few outcomes